Teleflex Incorporated (NYSE:TFX) Shares Bought by Janus Henderson Group PLC

Janus Henderson Group PLC lifted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 2.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,376,452 shares of the medical technology company’s stock after acquiring an additional 147,147 shares during the period. Teleflex accounts for about 0.7% of Janus Henderson Group PLC’s investment portfolio, making the stock its 18th largest position. Janus Henderson Group PLC owned 11.58% of Teleflex worth $1,329,704,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of the stock. Oregon Public Employees Retirement Fund boosted its holdings in shares of Teleflex by 1.2% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock worth $846,000 after acquiring an additional 46 shares in the last quarter. Cromwell Holdings LLC lifted its stake in shares of Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after purchasing an additional 49 shares during the period. Crossmark Global Holdings Inc. increased its position in shares of Teleflex by 1.9% during the second quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company’s stock worth $584,000 after acquiring an additional 53 shares in the last quarter. Apollon Wealth Management LLC boosted its holdings in shares of Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after buying an additional 55 shares during the last quarter. Finally, SRS Capital Advisors Inc. boosted its stake in Teleflex by 0.3% in the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after purchasing an additional 60 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE:TFX opened at $194.29 on Tuesday. Teleflex Incorporated has a 1-year low of $185.66 and a 1-year high of $257.85. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm has a market cap of $9.02 billion, a price-to-earnings ratio of 38.63, a price-to-earnings-growth ratio of 1.97 and a beta of 1.16. The company has a 50 day moving average price of $218.89 and a 200-day moving average price of $222.26.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same quarter in the previous year, the company posted $3.64 EPS. The firm’s revenue for the quarter was up 2.4% on a year-over-year basis. Equities research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.70%. Teleflex’s dividend payout ratio is currently 27.04%.

Wall Street Analyst Weigh In

TFX has been the subject of a number of analyst reports. Royal Bank of Canada decreased their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Mizuho lowered their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Truist Financial restated a “hold” rating and issued a $227.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Teleflex currently has a consensus rating of “Moderate Buy” and an average target price of $259.25.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.